ONC 201 Maintenance Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome After Stem Cell Transplant
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes Intervention: Drug: ONC201 Sponsor: Vijaya Bhatt Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Myelodysplastic Syndrome | Research | Stem Cell Therapy | Stem Cells | Transplants